Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remember when you are trading stocks you are trading against computers that Do not trade on emotions either fear or greed. Besides incomparable speed of computers the lack of emotions is the other advantage. Human traders can never match the speed but can try to limit emotions to decrease that advantage and if one can perform mental calculus regarding price/volume and recognise pattern trading and at least be aware that you are trading against computers you can lessen the speed advantage by anticipating the computer targets and patterns.
HFT Algos are harvesting cheap shares push down to set off stops and panic selling. Then raise the price to get those fear filled retail to sell on the bounce. 10q comes out Friday after close with whatever they were fearful to disclose then they could release the TLD Kraken on Teusday morning after the holiday.
There will be no bad TLD but they already warned us there will be large non cash losses due to options awards. Mearly bad optics but nothing concerning.
Get them while they are hot. Biotechs usually shake out before the big launch.
Likely it means 10q Friday after close and TLD Teusday after holiday.
Alexion was recently bought out for $39 billion. Moderna has a market cap of $49 billion. Once CytoDyn is approved for anything it will instantly be more profitable than both put together.
While both of these high flying market cap companies have some interesting technologies, Leronlimab has more potential then all of their pipelines put together AND has already a finished in stock product that has been proven safe in 1200 human trial patients some in an extremely fragile state and for durations exceeding five years. These other companies still need to develop then test their drugs. CytoDyn mearly needs to do Phase 2/3 pivotal studies in various indications therefore has a 3 to 5 year lead on everything they are going for except vaccine. But " dunta da da..drum roll" Leronlimab would likely be effective to prevent not only HIV and all Corona Viruses and others as Ebola, West Nile, Zika and others that use CCR5/RANTES pathway. Plus sub Q administration can be done in Doctors office or battlefield in case of BioWar.
Anyone want to buy some Moderna, Alexion or Gilead? No?
I did not think so.
CytoDyn actually has two deep playing safety and a monster of a linebacker to help protect against a score against your CYDY investment. Linebacker is Res HIV and safeties are Nash and Can Basket.
If news reports come out about remarkable recoveries of placebo patients from the trial after being switched to Leronlimab in the open label extension CYDY could get a share price boost while waiting for the top line data announcement. Possibilities of surprises are many.
Exactly. A wash and rinse performed by HFT computer algo trading. Only whales hedge funds, MMs and other Whales have the ability, equipment and connections to do that. Not shorts at all but professional longs accumulating shares at a cheaper price. Likely investing for clients so they must outperform the market to remain relevant and to charge their customers fees. Like the man says some well connected investors with superior knowledge want in at a discount. As the Man said this can be very bullish.... Wash and Rinse pattern.
Do not fear it.... buy the dips! Gird your gonads and fight for your investments in CytoDyn.
That makes a lot of sense for Merck to enter into a partnership with NWBO and then when NWBO has substantial earnings Merck could leverage those earnings to issue bonds to finance a buyout. This would also give the Companies time to integrate operations and personnel.
Do you mean Ken Fraiser the CEO of Merck? THAT KEN FRAISER?
I second the motion. It looks like account created to spread fudsickels. We just be getting close ....
28 million short shares is actually fairly low amount for a stock with 600 million shares. Less than 5% of the float. The problem for those shorts is they all might be forced to cover at once on a big event instead gradually as in a company that is improving incrementally. As soon as CYDY gets EUA they will instantly have more revenue than ModeRNA that now has $49 billion market cap and still losing money. CYDY will be turning a profit right out of the gate.
Well I hope they make a ton of money on their other short plays so they will have a lot of money to cover much higher when CYDY gets EUA and opens higher than $10 and shoots over $25 when all of a sudden there is a demand for 100s of millions of shares on the buy side from both Tutes and retail.
I get it. I was not criticizing your post just sharing what I found when looking into it.
I think it means there are a lot of high speed computer trades that the exchange is having trouble reporting when they happen. Today's drop was computer driven HF algo trading to manipulate the share price. That phenomena is a wide spread well known problem. Even Bernie Sanders knows about that.
Nothing. T trades are just reporting the volume that was not posted on time and sales as they happened during the day. CYDY closed at $4.73 not 4.63. Look up Form T reporting on Investopedia.
NWBO will not be stopping in Kansas City.
That is right. I would not expect to hear anything regarding trial until the end of January or early Feb.
There might be another surprise that gets PR first however.
Do not do anything based on fear FUD or other emotions or a fast moving volitilty spike up or down. The HFT Algos plucked the ticker strings today so expect that string to continue to vibrate with increased volitilty for the time being.
You are welcome T trades are meaningless. They are not after hours trades just reporting an amalgamation of trades that happened during day that were not reported on time and sales. On NASDAQ they will report two different kinds of amalgamation trades the MOC and LOC. The MOC is all the combined market on close executions and the LOC is the combined limit on close executions. Those are more meaningful as institutions often trade that way for their funds to avoid too much influence on price action during the day.
andore likely that the tape reporting on time and sales was not able to keep up with the pace of HFT so the MMs had to make Form T report after the close. It means nothing except the trading was fast and furious while the HFT were stealing legally by their many hundreds of wash trading/computer driven day trades. The HFT computers are faster than the MM reporting computers. That is one way they front run the market. Invisible to others as by the time it reports on Time and sales they have already moved the price and executed more trades. It is hard to hit the bid or ask in those HFT machine gun bursts because it has already moved before anyone but the HFT computer can see it.
A trade would mean there are buyers and sellers. I did not bother to calculate but it is likely an amalgamation at the VWAP for the day.
635414 shares T trade @ $4.6329 time 16:03:54
Only in the last few days have I seen T trades of this magnitude.
Today marks the end of most deaths in the placebo arm. Today the last enrolled in the placebo arm will get Leronlimab. Prayers go out that these last marked as sacrificial lambs are returned from deaths door and reunited with their loved ones.
I should have said separate the Men and Women from the boys and girls. My apologies to the ladies except the Bare Naked Lady shorts. Haha. Keep up those HFT trading Algos. I will keep buying those dips. Those work both ways. When the time is right they will flip the switch on the HFT Algos and spike the price into a nose bleed assent so none others will be quick enough to add before the spike. One should dig into a position they are comfortable with to hold over time. CYDY is derisked over time as they have several shots on goal with several indications with multiple regulatory agencies. CYDY is brilliantly managed in this particular regard.
HFT Algos control the vertical axis in the short term but longer term good DD in a sound company with good fundamental prospects win over time.
Jolly Rodger HFT Algos pirating shares off of weak players. The next few weeks will separate the men from the boys and girls and separate those weak hands from their shares. What happened with AMRN just before it skyrocketed? AMRN or any just before the big reveal.
Trading out of toppy blue chips now to add here in tranches.
Everyone has a plan until they are punched in the mouth with a double cross.
CYDY closed the Gap at $4.65 Golden cross tomorrow. Let's see if these technical indicators hold water and it turns bullish the rest of today and tomorrow. I am adding right fn here.
No absolutely and unequivocally NOT. The $4 requirements for that level is just on the very day of up list. You don't have to take my word for it just look around at other companies that up lifted. HGEN did a reverse split it get above $4 and up listed the very next day. You are confused with the continuing listing rule of $1 bid price but that can persist for nearly a year with extensions.
That's what I want shares of MRK BMY or AZN and sit back relax and collect the dividends.
Management might not want the taxable event that comes with a cash buyout and might want to participate in the future of DCVAX by having shares of the Company buying NWBO.
Silver lining of late 10K. NWBO can not dilute with more shares options or warrants as long as they are not current in their reporting.
Zero hold time.
That way they can do a Merger Acquisition with stock instead of cash and therefore do not have to issue more shares.
Early administration of Leron might have as good of efficacy in Covid the same as in HIV. Both virus invade the cells through similar mechanisms.
Once on deaths door it is much more difficult to rescue. 50% at that point is phenomenal.
Woof Woof!! A surprise up list by CytoDyn will annihilate short positions. The shorts have no such power. CytoDyn holds the cards and pocket aces.
The next short drive of the shorts then might get intercepted for a shut down after they try to reshort after blowing up on the open next week.
What are the chances CYDY shorts start their game off next week the way the Steelers just did? Ball goes way over head for score by Browns.
$7 plus
Maybe some are so off in the short thesis woods that they have no forward vision?
True. However to make proper potential comparisons for potential one should use same industry AND same types of drugs. So Apple and Amazon fail for comparison as well as Gilead as it has antiviral drug franchise. The best comparison the I can find for CytoDyn potential is Amgen. A 780x bagger. Because its franchise drugs and the ones that lead to the spectacular growth were immunology drugs for cancer and arthritis. Right in Leronlimab wheelhouse.
Everyone can run there own numbers for a big picture but start with a drug company and a similar drug and indications. Leronlimab in an immunological drug it is not an antiviral so Gilead is not the best to compare as it has narrow purpose antiviral drugs.
That is right. A warrant has time value like an option. It is normal, natural and proper to incentivize warrant holders to convert early for a decreased conversion price. That is fair and proper. This helps the company by providing much needed immediate cash, it helps the stockholders by unburning the some of the warrant overhang. The warrant holders got a fair deal surrendering the time value for a decreased warrant exercise price and likely agreed because they have a large stock position already and dumping this conversion is good for the company and therefore increases the value of their stock.
It looks like all the pieces are in place for a NASDAQ up list.
I hope Nader and the BOD will up list by surprise and thereby exposing any Naked Short sellers to the Dept. of Justice.